Study identifies possible new combination chemotherapy for patients with advanced prostate cancer

A role for combination therapy using two or more chemotherapy agents at the same time has not been well studied.  This week, however, results of a clinical trial presented at the American Society of Clinical Oncology meeting by researchers at The University of Texas MD Anderson Cancer Center may change the perspective on a role for combination chemotherapy in advanced disease.
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news